Dynamic loading enhances integrative meniscal repair in the presence of interleukin-1  by McNulty, A.L. et al.
Osteoarthritis and Cartilage 18 (2010) 830e838Dynamic loading enhances integrative meniscal repair in the presence
of interleukin-1
A.L. McNulty y, B.T. Estes y, R.E. Wilusz yz, J.B. Weinberg xk, F. Guilak yz*
yDepartment of Surgery, Duke University Medical Center, Durham, NC, USA
zDepartment of Biomedical Engineering, Duke University, Durham, NC, USA
xDepartment of Medicine, Duke University Medical Center, Durham, NC, USA
kVA Medical Center, Durham, NC, USAa r t i c l e i n f o
Article history:
Received 11 September 2009
Accepted 6 February 2010
Keywords:
Meniscus
Tissue repair
Mechanical loading
Bioreactor
Matrix metalloproteinase
Aggrecanase
Nitric oxide* Address correspondence and reprint requests
University Medical Center, Box 3093, Durham, NC 2771
Fax: 1-919-681-8490.
E-mail address: guilak@duke.edu (F. Guilak).
1063-4584/$ e see front matter  2010 Osteoarthriti
doi:10.1016/j.joca.2010.02.009s u m m a r y
Objective:Meniscal tears are a common knee injury and increased levels of interleukin-1 (IL-1) have been
measured in injured and degenerated joints. Studies have shown that IL-1 decreases the shear strength,
cell accumulation, and tissue formation in meniscal repair interfaces. While mechanical stress and IL-1
modulate meniscal biosynthesis and degradation, the effects of dynamic loading on meniscal repair
are unknown. The purpose of this study was to determine the effects of mechanical compression on
meniscal repair under normal and inﬂammatory conditions.
Experimental design: Explants were harvested from porcine medial menisci. To simulate a full-thickness
defect, a central core was removed and reinserted. Explants were loaded for 4 h/day at 1 Hz and 0%e26%
strain for 14 days in the presence of 0 or 100 pg/mL of IL-1. Media were assessed for matrix metal-
loproteinase (MMP) activity, aggrecanase activity, sulfated glycosaminoglycan (S-GAG) release, and nitric
oxide (NO) production. After 14 days, biomechanical testing and histological analyses were performed.
Results: IL-1 increased MMP activity, S-GAG release, and NO production, while decreasing the shear
strength and tissue repair in the interface. Dynamic loading antagonized IL-1-mediated inhibition of
repair at all strain amplitudes. Neither IL-1 treatment nor strain altered aggrecanase activity. Addition-
ally, strain alone did not alter meniscal healing, except at the highest strain magnitude (26%), a level that
enhanced the strength of repair.
Conclusions: Dynamic loading blocked the catabolic effects of IL-1 on meniscal repair, suggesting that
joint loading through physical therapy may be beneﬁcial in promoting healing of meniscal lesions under
inﬂammatory conditions.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The menisci are C-shaped ﬁbrocartilaginous tissues situated
between the femoral condyles and tibial plateau. These tissues are
required for normal biomechanical function of the knee, including
load bearing, shock absorption, joint congruity, and joint
stability1e3. The intact meniscus has been suggested to carry
approximately 50% of the load applied to the joint4, resulting in
approximately 10% strain in the medial meniscus5. Tears in the
meniscus are a common knee injury with nearly 15% of all athletic
knee injuries involving the meniscus6. In addition to the pain and
loss of function associated with the initial meniscal injury, damageto: Farshid Guilak, Duke
0, USA. Tel: 1-919-684-2521;
s Research Society International. Por loss of meniscal tissue is associated with progressive degenera-
tive changes in the joint that ultimately lead to osteoarthritis
(OA)7e11. Long-term studies have shown that 50% of patients with
a meniscal injury develop OA within 10e20 years12. Therefore,
current clinical therapies for meniscal injury seek to preserve and
repair damaged tissue.
The pathogenesis of osteoarthritic degeneration following knee
injury appears to involve the anti-anabolic and pro-catabolic
activity of inﬂammatory cytokines, such as interleukin-1 (IL-1),
which are upregulated in injured and degenerated joints13,14. In
patients without rheumatic disease or joint effusion, less than
20 pg/mL IL-1b has been measured in the joint at autopsy15. On the
other hand, in patients undergoing an arthroscopy following
a meniscal tear, the concentration of synovial ﬂuid IL-1a is between
25 pg/mL and 175 pg/mL16. IL-1b levels are also elevated in patients
with rheumatoid arthritis (RA; 115 pg/mLe193 pg/mL) and OA
(21 pg/mLe146 pg/mL)15,17. Additionally, full-thickness meniscalublished by Elsevier Ltd. All rights reserved.
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that IL-1a may be produced for several weeks after the initial
meniscal tear.
IL-1 upregulation in the joint inducesmany degradative and pro-
inﬂammatory pathways13,14,19,20. IL-1 increases the production of
the inﬂammatory mediators nitric oxide (NO)21e25 and prosta-
glandin E2 (PGE2)21,24,26 in a dose-dependent manner. Additionally,
IL-1 upregulates matrix metalloproteinases (MMPs)23,24,27,28,
increases proteoglycan release22,24, suppresses collagen synthesis24,
and upregulates tumor necrosis factor (TNF) expression23 in
meniscal cells and explants. IL-1 also upregulates aggrecanase-1
(ADAMTS-4) activity but not aggrecanase-2 (ADAMTS-5) activity
in bovine cartilage explants29 and porcine chondrocyte-agarose
cultures30,31. Both acute32 and chronic33,34 exposure to IL-1
inhibits integrative meniscal repair in vitro by decreasing the
shear strength of repair and suppressing cell accumulation and
tissue formation in the interface. In an explant model of meniscal
repair, treatment with IL-1 receptor antagonist (IL-1ra)33, MMP
inhibitors28, or the anabolic growth factor TGF-b135 has shown
promise in overcoming some of the degradative effects of IL-1.
In addition to changes in the biochemical environment of the
joint, trauma or arthritis can also alter the biomechanical envi-
ronment of the joint. In articular cartilage, many studies have
shown that mechanical stress in the joint is an important factor in
the regulation of chondrocyte activity36. The general consensus of
these studies is that static compression suppresses matrix biosyn-
thesis, while cyclic or intermittent loading at speciﬁc frequencies
can stimulate chondrocyte metabolism (Ref. 36 for review).
However, little information is available regarding the response of
meniscal cells to mechanical stress. Meniscal explants subjected to
static compression showed decreased expression of type I and II
collagen37, increased MMP-1 expression37, and decreased biosyn-
thetic activity, as measured by 35S-sulfate and 3H-proline
incorporation38. Dynamic mechanical compression increases
proteoglycan and total protein synthesis22 and NO and PGE2
production by meniscal explants39,40. Additionally 20% compres-
sive strain of porcine explants caused increased expression of
the following catabolic mediators: inducible NO synthase (NOS2),
IL-1a, MMP-1, MMP-3, MMP-13, and a disintegrin and metal-
loproteinase with thrombospondin 4 (ADAMTS-4)41,42. On the
other hand, in the presence of IL-1, mechanical compression
inhibits NO production22. Biaxial cyclic tensile stretch of isolated
meniscal cells inhibited the catabolic and pro-inﬂammatory effects
of IL-123,43 by inhibiting NOS2, MMP expression, and NO
production. Biaxial stretch also counteracted IL-1-dependent
stimulation of NOS2, RANK, and RANKL in meniscal cells, poten-
tially via inhibition of NF-kB23,43. These ﬁndings suggest that
mechanical loading can overcomemany of the inﬂammatory effects
of cytokines on meniscal cells; however, the effects of mechanical
compression on repair of meniscal lesions are not known.
The goal of this study was to investigate the effects of dynamic
mechanical compression on meniscal repair in the presence or
absence of the inﬂammatory cytokine IL-1. We hypothesized that
mechanical compression at lower magnitudes (<10%) would
enhance meniscal repair under both normal and inﬂammatory
conditions, but higher magnitudes (>10%) of dynamic compression
would inhibit repair. We used an in vitromodel system28,32e34,44 to
examine the effects of 0%e26% dynamic compressive strain on the
integrative repair of meniscal explants treated either with or
without IL-1. Explants were dynamically loaded for 14 days and the
media were assessed for MMP activity, aggrecanase activity,
sulfated glycosaminoglycan (S-GAG) release, and NO production.
Meniscus healing was investigated by mechanical testing of the
explants to determine the interfacial shear strength, and histology
was performed to visualize tissue repair.Materials and methods
Meniscal repair model system
An explant model systemwas used to study integrative repair of
themeniscus44. Medialmenisci were harvested from2 to 3-year old
skeletally mature female pig knees obtained from a local abattoir.
Cylindrical explants were harvested from the femoral surface of the
middle one-third of the meniscus, using a 5 mm biopsy punch
(Miltex, Inc, York, PA) oriented perpendicular to the meniscal
surface. Using a custom built cutting device, explants were cut to an
average thickness of 2.4 mm. A central 3 mm core was punched
completely through each explant, using a biopsy punch (Miltex, Inc),
and immediately reinserted in the same orientation as a model of
a full-thickness meniscal tear. Explants were placed in Costar ultra-
lowattachment surface 24-well plates (Corning Inc.; Corning, NY) in
the center of polyacetal retaining rings. Samples were incubated in
Dulbecco's Modiﬁed Eagle's Medium (DMEM; Invitrogen, Carlsbad,
CA), containing 1000 U/mL penicillin/streptomycin (Invitrogen) for
1 h at 37C. This mediumwas removed, and explants were cultured
in DMEM containing 10% heat inactivated fetal bovine serum
(HyClone, Logan, UT), 0.1 mM non-essential amino acids (Invi-
trogen), 10 mM HEPES buffer solution (Invitrogen), 100 U/mL
penicillin/streptomycin, and 37.5 mg/mL L-ascorbic acid 2-phos-
phate (SigmaeAldrich, St. Louis, MO). Explants were cultured in
amechanical compression bioreactor for 14 days at 37C and 5%CO2.
Media were collected and replaced every 3 days.
Mechanical compression bioreactor
A closed-loop displacement controlled bioreactor was designed
and manufactured to apply dynamic, unconﬁned compressive
deformational loading to 24 specimens simultaneously. The instru-
ment consists of a rotary stepper motor (Oriental Motor, Torrance,
CA) set to microstep at 4000 steps/rev (0.09/step) with an optical
encoder for closed-loop feedback control. The stepper motor drives
a linear stage (Danaher Motion, Wood Dale, IL) that is connected to
a loading platform housing 24 individual polyacetal pistons. The
pistons were designed such that the posts slip freely through the
loadingplatform if not locked inplace, ensuring that all pistonsare in
contact with their respective explant prior to being locked to the
plate. The design of the instrument and the written code (LabView
6.1, National Instruments, Austin, TX) allow for precise displacement
of the loading platformwith sub-micron resolution.
Explants (n 9 per treatment group, each from different porcine
menisci) were cultured in the mechanical compression bioreactor
at 37C/5% CO2 and loaded sinusoidally at 1 Hz to strains of 1%
0.2% (mean standard deviation),10% 1%, or 26% 4% for 4 h/day
for 14 days. Unstrained samples were cultured in the bioreactor in
parallel with strained samples; however, the pistons were locked
into place approximately 1 mm above the explants. For each strain,
explants received either control media ormedia containing 100 pg/mL
recombinant porcine IL-1a (R & D Systems, Minneapolis, MN).
MMP activity assay
Total speciﬁc MMP activity was measured in media samples
from day 3 using the quenched ﬂuorogenic substrate Dab-Gly-Pro-
Leu-Gly-Met-Arg-Gly-Lys-Flu (New England Peptide; Gardner, MA)
as described previously28,32,45.
Aggrecanase activity assay
Aggrecanase activity was measured in media samples from day
3, using a commercially available ﬂuorescent substrate (Anaspec;
Fig. 1. MMP activity in the media of meniscal repair model explants that were exposed
to no strain, strain, no strainþ IL-1, or strainþ IL-1. The strains tested were 1% (top
panel), 10% (middle panel), and 26% (bottom panel). The MMP activity is expressed as
ﬂuorescence units (FU)/mg wet weightþ standard error. *: P< 0.05 compared to all
other treatments.
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Samples were run in duplicate and incubated at 37C for 30 min in
the dark. Fluorescence was measured at 340 nm excitation and
405 nm emission. The data are expressed as ﬂuorescence units
(measured ﬂuorescenceminus the ﬂuorescence in the blankmedia)
corrected for the wet weight of the tissue. Recombinant human
ADAMTS-4 (5 mg/mL; Anaspec) was included as a positive control
for the assay. Additionally, porcine cartilage explants that were
treated for 72 h with 1 ng/mL IL-1a were used to conﬁrm cross-
reactivity of the substrate with porcine ADAM-TS4.
S-GAG release
Total S-GAG release was measured in day 3 media, using the 1,9-
dimethylmethylene blue (DMB) assay47. For this assay, standards
ranging from 0 mg/mL to 100 mg/mL bovine trachea chondroitin-4-
sulfate type A (Sigma, St. Louis, MO) were prepared in control
media. Forty microliters of standards and samples and 125 mL/well
of DMB reagent were added to a 96-well plate in duplicate.
Absorbance was read at 540 nmwithin 5 min of DMB addition and
the total mg of S-GAG released from each sample was corrected for
the wet weight of the tissue.
NO release
Total NO production was assessed by measuring the concen-
tration of total nitrate and nitrite (or NOx) in day 3 media, as
detailed previously48. All media samples and standards
(0 mMe320 mM NaNO3 in culture media) were ﬁltered through
Micron Ultracel YM-10 ﬁlters (Millipore, Bedford, MA) and diluted
1:2 in dH2O to eliminate interference of protein and media
components. All nitrate was then converted to nitrite, using nitrate
reductase (Roche Diagnostics; Mannheim, Germany), and total
nitrite concentrations were determined using the Greiss reagent.
Absorbance was read at 540 nm and total mmol NOx was normal-
ized to the wet weight of the tissue.
Biomechanical testing
Interfacial shear strength of repair between the inner core and
outer ring of meniscal repair model explants was determined after
14 days in culture, using a push-out test as described previously44.
The peak force at failure was normalized by the area of the interface
between the inner core and outer ring to determine interfacial
shear strength. Measured sample thickness was used to determine
the actual surface-to-surface compressive strain applied to each
explant during deformational loading.
Histological staining
Meniscal repairmodel explantswere processed for histology after
14 days in culture. Samples were ﬁxed overnight in 4%
paraformaldehyde (Electron Microscopy Sciences, Hatﬁeld, PA),
containing 100 mM sodium cacodylate trihydrate (Electron Micros-
copy Sciences) at pH 7.4 and 4C. Samples were dehydrated in EtOH,
inﬁltrated with xylene, and parafﬁn embedded. Sections were
stained with Harris Hematoxylin with glacial acetic acid (Poly
Scientiﬁc, Bay Shore, NY), 0.02% aqueous fast green (SigmaeAldrich),
and Accustain Safranin O solution (SigmaeAldrich).
Statistical analyses
Statistical analyses were performed using Statistica 7.0 (StatSoft
Inc., Tulsa, OK). A two-factor ANOVA and the NewmaneKeuls post
hoc test were performed to determine signiﬁcant differences(a¼ 0.05) and the interactive effect of strain and IL-1. The rela-
tionship between interfacial shear strength and actual applied
strain was determined using linear regression.Results
MMP activity in the media of meniscal repair model explants
was increased by IL-1 treatment in the absence of strain (Fig. 1;
P< 0.0005). However, application of strain at 1%, 10%, and 26%
blocked the increase in MMP activity due to IL-1 (P< 0.05). Inhi-
bition of IL-1-mediated MMP activity was most pronounced at
lower strains (P< 0.0005 for 1% and 10%), as compared to 26%
strain (P< 0.05). Additionally at both 1% and 10% strains, there was
an interactive effect of strain and IL-1 on MMP activity (P< 0.001).
In the absence of IL-1, therewas no change inMMP activity at any of
the strains tested.
Aggrecanase activity was measurable in all treatment groups
(Fig. 2). However, neither IL-1 treatment nor strain altered aggre-
canase activity, as compared to control samples. The combination
of IL-1 and strain also did not affect aggrecanase activity.
In the absence of strain, S-GAG release into the media was
enhanced approximately 5-fold by IL-1 treatment (Fig. 3;
P< 0.0005). Strains of both 1% and 10% were effective in reducing
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had no effect on the S-GAG release in the presence of IL-1. At both
1% and 10% strains there was an interactive effect of strain and IL-1
(P< 0.05). For all strains there was a signiﬁcant effect of IL-1 that
contributed to S-GAG release into the media from the meniscal
repair explants (P< 0.00001). None of the strains tested altered the
S-GAG release into the media in the absence of IL-1.
NO release into the media was increased by IL-1 treatment in
the absence of strain (Fig. 4; P< 0.0005). However, all tested strains
reduced the IL-1-mediated NO release (P< 0.005). At all strains,
there was an interactive effect of strain and IL-1 that contributed to
NO release into the media (P< 0.05). In the absence of IL-1, none of
the strains tested altered the NO release into the media from
meniscal repair explants.
In the absence of strain, IL-1 decreased the integrative shear
strength of repair in meniscal repair model samples (Fig. 5;
P< 0.05). Dynamic compression at 1%, 10% or 26% strain increased
the shear strength of IL-1 treated explants to strengths that were
comparable to that measured in unstrained explants (P 0.01).
Additionally, there was a positive correlation between increasing
shear strength in the presence of IL-1 and actual applied strain
(r2¼ 0.25; P< 0.00005). At 1% and 26% strains, there was a signiﬁ-
cant effect of cytokine (P< 0.05) with an average 47% decrease in
strength of repair, and at all strains there was a signiﬁcant effect of
loading (P< 0.005) that contributed to the integrative shear
strength of repair. In the absence of IL-1, at 26% strain, there was
a 2-fold increase in the shear strength of repair compared to
unstrained samples (P< 0.005), but there was no effect of either 1%Fig. 2. ADAMTS-4 activity in the media of meniscal repair model explants that were
exposed to no strain, strain, no strainþ IL-1, or strainþ IL-1. The strains tested were 1%
(top panel), 10% (middle panel), and 26% (bottom panel). The aggrecanase activity is
expressed as ﬂuorescence units (FU)/mg wet weightþ standard error.
Fig. 3. S-GAG release into the media of meniscal repair model explants that were
exposed to no strain, strain, no strainþ IL-1, or strainþ IL-1. The strains tested were 1%
(top panel), 10% (middle panel), and 26% (bottom panel). The S-GAG release is
expressed as mg S-GAG/mg wet weightþ standard error. *: P 0.005 compared to all
other treatments. þ: P< 0.01 compared to no strain and strain.or 10% strains alone. Furthermore, there was also a positive corre-
lation between increasing shear strength of repair and actual
applied strain (r2¼ 0.14, P< 0.005).
Histological analysis of unstrained and all strained meniscal
repair model explants revealed healing of themeniscal defect at the
interface over 14 days (Fig. 6). The interface was ﬁlled with an
extracellular matrix that stained strongly with fast green, revealing
the presence of collagen ﬁbers, and moderately with Safranin O,
indicating the presence of proteoglycans. On the other hand, no
visible tissue repair was detected in IL-1-treated explants that were
not strained. Additionally, IL-1 treatment resulted in loss of
proteoglycan staining in the meniscal extracellular matrix.
However, IL-1-treated explants that received 1%, 10%, or 26% strain
showed increased tissue repair at the interface.
Discussion
Our results demonstrate that dynamic mechanical loading can
overcome some of the degradative effects of IL-1 on meniscal
Fig. 4. NO release into the media of meniscal repair model explants that were exposed
to no strain, strain, no strainþ IL-1, or strainþ IL-1. The strains tested were 1% (top
panel), 10% (middle panel), and 26% (bottom panel). The NO release is expressed as
mmol/g wet weightþ standard error. *: P< 0.005 compared to all other treatments. þ:
P< 0.05 compared to no strain.
Fig. 5. Integrative shear strength of repair for meniscal repair model explants that were
exposed to no strain, strain, no strainþ IL-1, or strainþ IL-1. The strains tested were 1%
(top panel), 10% (middle panel), and 26% (bottom panel). The shear strength of repair is
expressed as kPaþ standard error. *: P< 0.05 compared to all other treatments. #:
P< 0.005 compared to no strain and no strainþ IL-1. þ: P< 0.01 compared to 26%
strainþ IL-1.
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MMP activity, S-GAG release, NO production, decreases in tissue
formation in the interface, and consequently decreases in the shear
strength of repair. However, dynamic compression at 1%, 10%, or
26% strain blocked the IL-1-mediated inhibition of meniscal repair.
Interestingly, mechanical loading under non-inﬂammatory condi-
tions did not alter the healing of meniscal lesions. These ﬁndings
support our hypothesis that, in an inﬂammatory environment,
meniscal repair was enhanced by low magnitudes of dynamic
loading, but refute our hypothesis that high magnitudes of strain
would inhibit meniscal repair. Additionally, our results refute the
hypothesis that dynamic loading enhances repair under control
(non-inﬂammatory) conditions, with the exception of the highest
applied strain, a level that led to increased integrative shear
strength of repair in the absence of IL-1. Our ﬁndings suggest that
dynamic loading of the knee following a meniscal injury may be
a beneﬁcial physical therapy regime to promote healing of meniscal
lesions and to combat the degradative effects of inﬂammation.
However, further studies are necessary to translate this work in vivo
and to elucidate the exact nature of the therapy.
The effects of biomechanical factors on cartilaginous tissues have
been shown to be dependent on the type of load, magnitude, andfrequency of loading. It has been estimated that in situ compressive
strains range fromapproximately 10% to15% in normalmenisci4 and
increase to 20% following 30%e60% meniscectomy5. Using a similar
compression device,McHenry et al. have shown that the application
of 0.05 MPa or 0.1 MPa of dynamic compressive stress to porcine
meniscal explants resulted in ﬁnal measured strains of 10% or 20%,
respectively49. At higher magnitudes of loading, meniscal explants
appear to exhibit a pro-inﬂammatory response, characterized by
increased production of NOS2 and PGE240. Thus, to examine a range
of physiologic and hyper-physiologic conditions, we assessed the
effects of dynamic compression at strains ranging from 0% to 26% at
a frequency of 1 Hz.
In this study, loading of meniscal repair explants in the absence
of IL-1 had no effect on MMP activity. Experiments on isolated
chondrocytes and ﬁbrochondrocytes have also shown that 6% cyclic
tensile strain alone does not alter MMP activity50,51. Other studies
in superﬁcial porcine meniscal explants have shown that expres-
sion of MMP-1, MMP-3, and MMP-13 was increased by 2 h of 20%
strain42. Additionally, bovine cartilage explants loaded at 0.5 MPa
and 1 Hz for 3 h showed increased MMP-2 and MMP-9 expression,
activation, and activity52. Dynamic compression of porcine tibial
plateau cartilage explants at 0.1 MPa and 0.5 Hz for 6 h increased
Fig. 6. Histological images of parafﬁn embeddedmeniscal repairmodel explants stainedwith Hematoxylin to identify the cell nuclei (black), fast green (green) to identify the collagen
ﬁbers, and Safranin O (red) to stain proteoglycans. Samples were incubated with no IL-1 or 100 pg/mL IL-1 and subjected to 0%, 1%, 10%, or 26% strain. Scale bar is equal to 100 mm.
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metalloproteinase-2 (TIMP-2)53. Differences in our results and
previous studies may be due to intrinsic tissue differences, duration
of loading, type of loading, actual applied strain, frequency, and/or
assessed outcome measures (enzyme activity vs gene expression).
In this study, dynamic compressive loading blocked IL-1-medi-
ated increases in MMP activity in the media of meniscal repair
model explants. In agreement with our results, 2% cyclic biaxial
tensile strain of isolated rheumatoid synovial cells reduced the
mRNA and protein levels of MMP-1 andMMP-13 and decreased the
activity of these enzymes in the presence of IL-1b and use of
a transcriptional inhibitor suggested that mechanical loading
reduced the activity of the MMPs at a post-transcriptional level54.
Biaxial cyclic tensile strain has also been shown to antagonize IL-1b
effects in chondrocytes and temporomandibular ﬁbrochondrocytes
by reducing IL-1-mediated increases in MMP-1 mRNA and protein
levels and increasing TIMP-2 expression50,51. Loading-induced
decreases in MMP expression and increases in TIMP expression
are consistent with our results demonstrating a net decrease in
MMP activity with loading in the presence of IL-1. However, the
speciﬁc MMPs involved in IL-1-mediated degradation of meniscal
repair explants are currently unknown. In a previous study, we have
shown that the inhibition of individual MMPs was not sufﬁcient to
overcome the effects of IL-1; however, there was no speciﬁc inhib-
itor of MMP-1 activity available at the time28. In contrast, broad
spectrum inhibition of MMP activity increased repair in the pres-
ence of IL-1. Thus either MMP-1 is driving the degradation due to
IL-1 or a combination ofMMPs is necessary tomediate these effects.
IL-1 increased S-GAG release into the media, presumably
through the upregulation of MMPs, aggrecanases, and other
degradative enzymes. ADAMTS-4 activity was not upregulated by
IL-1, suggesting that this enzyme is not mediating the increase in
S-GAG release. Our data are consistent with a recent study in
immature bovine meniscus showing that inhibition of MMPs but
not ADAMTS-4 and ADAMTS-5 was effective at blocking IL-1-
mediated release of S-GAGs and decreases in mechanical
properties55. However, bovine meniscus has been shown to upre-
gulate aggrecanases in response to TNF-a treatment56. Previous
studies have shown that ADAMTS-4 is the major aggrecanase
upregulated by IL-1 in porcine chondrocytes30. Therefore, in the
presence of IL-1, MMPs are likely the predominant degradativeenzymes causing the release of S-GAGs. However, it is possible that
other aggrecanases or degradative enzymesmay also be involved in
the IL-1-mediated catabolism of the extracellular matrix.
Physiologic magnitudes (1% or 10%) of dynamic compressive
strain blocked the IL-1-mediated release of S-GAGs, while hyper-
physiologic strain (26%) did not have a signiﬁcant effect on S-GAG
release in the presence of IL-1. High magnitudes of strain have
previously been shown to be catabolic57, suggesting that 26% strain
may be activating additional pathways that prevent loading from
antagonizing the IL-1-mediated release of S-GAGs. Other studies
have shown that 10% dynamic strain at 1 Hz for 3 h/day of young
bovine chondrocyte-seeded agarose constructs was not sufﬁcient
to block the IL-1-induced S-GAG loss58. The differences in our
results are likely due to assessment of meniscal explants vs isolated
chondrocytes in agarose. In our study, dynamic loading alone had
no effect on S-GAG release into the media. However, other studies
have shown that 2 h of 20% strain at 1 Hz is sufﬁcient to increase
S-GAG release from porcine meniscal explants49. This difference
may be due to the short-term loading regime (only 1 day for 2 h vs
14 days for 4 h/day), as previous studies have shown that under
normal culture conditions, meniscus explants show signiﬁcant loss
of S-GAGs, which may obscure additional increases caused by
mechanical loading or other stimuli33.
Dynamic loading of meniscal repair explants also had no effect
on NO release. Experiments performed by Agarwal and colleagues
using a variety of different cell types have consistently shown no
effect of dynamic tensile strain on NOS2 expression23,51 or NO
production50. Furthermore, porcine meniscal explants subjected to
0%e20% strain have shown no change in NO release41. However,
other studies have shown conﬂicting results from decreased NO
release by 15% strain of chondrocyte-agarose constructs59,60 to
increased NO production by porcine meniscal explants subjected to
dynamic compressive stresses of 0.0125 MPae0.5 MPa at 1 Hz for
24 h39,40. These differences are likely attributable to the different
model systems and magnitudes of the applied stress or strain,
particularly the overall duration of loading. In this study, dynamic
loading suppressed the IL-1-mediated upregulation of NO release.
In agreement with our results, many other studies have also
demonstrated that dynamic compression and dynamic strain
antagonize IL-1-induced NOS2 expression23,51 and production of
NO22,50,59,60. Strain-induced suppression of the catabolic effects of
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followingmeniscal injury, perhaps providing an opportunity for the
intrinsic repair capacity of the tissue33,34 to heal themeniscal lesion.
Interestingly, loading alone increased the shear strength of
repair at the highest strain tested. In addition, the strain applied to
each meniscal repair explant correlated with increased shear
strength, suggesting that higher strains would bemost beneﬁcial to
promote integrative meniscal repair. In the absence of strain,
meniscal explants exhibited an intrinsic repair response that is
consistent with previous studies in meniscus33,44,61 and articular
cartilage62e65. The integrative repair of cartilage is dependent upon
the migration and proliferation of viable cells into the defect62 and
cell-mediated biosynthesis, including collagen production62,64 and
cross-linking65.
Many studies have analyzed the effects ofmechanical loading and/
or IL-1 on the expression and synthesis of both collagen and proteo-
glycans with mixed results. In explants of cartilage or meniscus,
dynamic loading alonehas been shown tohave awide range of effects
from no change in aggrecan transcript levels37 or proteoglycan
synthesis50,51 to upregulation in expression42,53,59 and synthesis60,66.
A similar range of effects has been reported with respect to collagen.
Dynamic loadingalonehasbeenshowntocausenochange incollagen
ImRNA levels42, decreased type II collagen transcript levels37, noeffect
oncollagen II transcription51,59, increased collagen II expression53, and
enhanced [3H]-thymidine incorporation60,66. However, in the pres-
ence of IL-1, dynamic loading is generally anabolic, resulting in an
increase in expression59 and synthesis of aggrecan50,51,60,66. For
collagen, dynamic loading in the presence of IL-1 had no effect on
collagen II transcript levels in one experiment59, but showed an
increase in collagen II expression51 and [3H]-thymidine incorpora-
tion60,66 in several other studies. All of these results suggest that
loading alone can have disparate effects depending on the experi-
mental parameters.
In this study, we demonstrated that dynamic loading blocks the
pro-inﬂammatory effects that are mediated by IL-1 and promotes
integrative meniscal repair in an inﬂammatory microenvironment.
Mechanical loading of articular cartilage can also inhibit IL-1-
induced matrix degradation67. Interestingly, mechanical loading of
meniscal repair model explants was more effective than IL-1ra33,
MMP inhibitors28, or the anabolic growth factor TGFb135 in
promoting integrative meniscal repair in the presence of IL-1. The
mechanism(s) by which dynamic loading antagonizes the effects of
IL-1 need to be investigated further. Mechanical loading may
regulate IL-1 expression by meniscal ﬁbrochondrocytes. A slight
induction of IL-1a, but not IL-1b transcript levels, has been
measured in porcine menisci subjected to 20% strain41 but cyclic
hydrostatic pressure suppresses IL-1b expression in rabbit
menisci68. It is also possible that mechanical loading caused
a downregulation in the IL-1 type I receptor and/or an upregulation
in the type II IL-1 decoy receptor66,69. Under 50% static compres-
sion, IL-1ra blocks decreases in cartilage explant proteoglycan
synthesis70, suggesting a role for the IL-1 receptors inmediating the
effects of load. Preloading for 1 h with cyclic tensile strain was
unable to signiﬁcantly decrease NOS2 expression and NO produc-
tion in chondrocytes treated with IL-1, suggesting that strain alone
is unable to downregulate the cell surface IL-1 receptors51.
However, these experiments did not directly assess receptor
number and did not address the idea that a synergism between
mechanical loading and IL-1 may be required to diminish the cell
surface receptors. Alternatively, mechanical loading may regulate
IL-1 signaling mediators that are downstream of the IL-1 receptor,
such as NF-kB57, RANK, and RANKL43. Dynamic loading and IL-1
have been shown to be anti-inﬂammatory by suppressing not
only the catabolic effects of IL-1 but also by diminishing expression
of other pro-inﬂammatory factors, such as TNF-a23.In summary, our data suggest a beneﬁcial effect of dynamic
loading in promoting repair of meniscal lesions in an inﬂammatory
microenvironment, such as a knee joint following meniscal injury,
meniscal repair surgery, or arthritis. Our data further suggest the
potential usefulness of physical rehabilitation treatment for
meniscal lesions, but more research is needed to fully elucidate the
mechanism(s) of IL-1 inhibition and translation of this work into
clinical practice.
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